Previous 10 | Next 10 |
Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire BRIDGEWATER, N.J. , Jan. 2, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious...
2023-12-14 17:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Insmed To Present at the Nasdaq 49th Investor Conference PR Newswire BRIDGEWATER, N.J. , Nov. 29, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare dis...
2023-11-25 16:32:53 ET More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc. Mirum Pharmaceuticals, Inc. (MIRM) Q3 2023 Earnings Call Transcript BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript Immunocore: First Half Of 2024 IMC-F106...
Insmed To Present at Two November Conferences PR Newswire BRIDGEWATER, N.J. , Nov. 8, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today ...
Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the Globe PR Newswire — Company-wide day of service brings more than 700 employees together to volunteer in 25 locations throughout the U.S., Europe , and Japan — BRIDGE...
Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List PR Newswire -- Insmed Leads Science Top Employers List for Third Consecutive Year -- BRIDGEWATER, N.J. , Oct. 26, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global bioph...
2023-10-26 15:02:10 ET Insmed, Inc. (INSM) Q3 2023 Earnings Conference Call October 26, 2023, 08:30 ET Company Participants Bryan Dunn - IR William Lewis - President, CEO & Chairman Sara Bonstein - CFO Conference Call Participants Andrea Tan - Gol...
2023-10-26 07:33:19 ET More on Insmed Insmed's Arikayce: A High Flyer With A Heavy Load Insmed Incorporated (INSM) Q2 2023 Earnings Call Transcript Insmed gains as antibacterial agent hits main goal in Phase 3 trial Seeking Alpha’s Quant Rating on Insm...
Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update PR Newswire —ARIKAYCE ® (amikacin liposome inhalation suspension) Total Revenue of $79.1 Million for the Third Quarter of 2023 Reflects Highest Quarter of Sales Since Launch an...
News, Short Squeeze, Breakout and More Instantly...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update PR Newswire — ARIKAYCE ® (amikacin liposome inhalation suspension) Total Revenue of $75.5 Million for the First Quarter of 2024, Reflecting 16% Annual Growth Over the First Qua...
Insmed To Present at the BofA Securities Health Care Conference 2024 PR Newswire BRIDGEWATER, N.J. , May 7, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with seriou...